Researchers have published a peer-reviewed study of two Sinopharm COVID-19 vaccines - with the results showing strong efficacy in protecting against COVID-19.
The findings were published overnight in the Journal of the American Medical Association after more than 40,000 volunteers were given either a placebo, or one of two vaccines.
The two inactivated vaccines showed 72.8 per cent and 78.1 per cent efficacy.
The report concluded: "Treatment of adults with either of 2 inactivated SARS-CoV-2 vaccines significantly reduced the risk of symptomatic COVID-19, and serious adverse events were rare."
None of the volunteers given an active vaccine developed severe disease, compared with two of those given placebo.
The study was completed by researchers in Wuhan, China, and the UAE, including Dr Nawal Al Kaabi of the Abu Dhabi Health Services Company, (SEHA).
6 missiles, 21 drones intercepted by UAE air defences on Monday
H.H. Sheikh Mohammed says over AED2.8 billion raised for 'Edge of Life' campaign
One dead after missile falls on vehicle in Abu Dhabi's Al Bahyah
Fire breaks out after drone hits Umm Al Quwain building
RTA announces Eid free parking, public transport timings
No injuries as authorities contain fire at Fujairah Oil Industry Zone
Dubai closes some routes heading to airport road
